Search by keywords: Connect with us Stay Informed. Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters. Newsletter Sign Up 1844 News Items found MSK Supports STEM Education at Yankee Stadium Science Fair Tuesday, May 16, 2023 Three MSK researchers served as guest judges at the event, which celebrated students’ academic achievements. Feature 17 Gerstner Sloan Kettering Students Will Graduate in 2023 Monday, May 15, 2023 Seventeen scientists are poised to receive their PhD degrees from the Gerstner Sloan Kettering Graduate School of Biomedical Sciences. Their years of dedication and training will be recognized on May 17, 2023, as part of Memorial Sloan Kettering’s 44th annual academic convocation. Expansion of Cell-to-Cell Communication Drives the Early Development of Pancreatic Cancer, New Research in Mice Finds Thursday, May 11, 2023 New MSK research combined sophisticated genetically engineered mouse models and advanced computational methods to map the earliest cell states leading to pancreatic ductal adenocarcinoma (PDAC), the most common type of pancreatic cancer. In the Clinic New Combination Drug Treatment Helps Some People With Stage 4 Kidney Cancer Wednesday, May 10, 2023 An international phase 3 clinical trial has shown that adding a targeted therapy to a standard combination for stage 4 kidney cancer is more effective than giving the standard treatment alone, although the new combination has significant side effects. The Right Moves: How Studying Cell Movement During Embryonic Development May Offer New Insights Into Cancer Metastasis Wednesday, May 10, 2023 New insights into the way cells break away from a tissue during embryonic development may also shed new light on the same process in the context of cancer metastasis. MSK Discovery of ESR1 Gene Mutation Leads to Approval of Breast Cancer Drug Elacestrant Wednesday, May 3, 2023 Learn how an MSK lab discovery in 2013 paved the way for the approval of a new breast cancer drug 10 years later. Pinpoint Accuracy: How Dr. Elenitoba-Johnson Helps Lead the Diagnosis of Cancer at MSK Monday, April 24, 2023 Learn about Dr. Kojo Elenitoba-Johnson, who leads teams of Memorial Sloan Kettering experts in interpreting lab tests and diagnosing cancer as the inaugural Chair of the MSK Department of Pathology and Laboratory Medicine. He is also a member in the Human Oncology and Pathogenesis Program. MSK Research Highlights, April 21, 2023 Friday, April 21, 2023 New MSK research finds adherence is a hurdle for home-based colorectal cancer tests; sheds new light on tumor-associated macrophages in glioblastoma; identifies statins as a promising addition to treatment for HER2-positive gastric cancer; and describes how a new single-cell transcriptome atlas opens the “black box” of early human embryo development. Quantitative Biology Fellowship Targets Cancer With Math and Computer Science Wednesday, April 19, 2023 Learn about the Marie-Josée Kravis Fellowship in Quantitative Biology, a two-year postdoctoral fellowship that aims to build a new generation of skilled quantitative biologists who specialize in cancer. Finding The Gut Microbiome and Cancer: MSK Researchers Present New Findings Wednesday, April 19, 2023 Research led by Josie Robertson Investigator Karuna Ganesh provided clues that microbiomes might explain the increase in colorectal cancer among younger patients. Pagination Load More Book traversal links for Newsroom Previous Newsroom Next Cancer Vaccine Could Prevent Neuroblastoma From Returning After Antibody Treatment